Thursday, May 30, 2019
9:00 AM to 5:00 PM


Boston Bar Association
16 Beacon Street, Boston, MA

The Health Care industry is complex and constantly evolving to adapt to changes in societal needs, research breakthroughs, regulatory and policy shifts, compliance issues, and more. Boston is a global leader in healthcare, home to world-renowned hospitals, medical schools, research institutions, and insurance networks. Within this vast, growing ecosystem are leading lawyers with deep industry knowledge to help guide clients through these legal and regulatory changes and seize opportunities for growth and collaboration to further improve the health care system.

The BBA’s inaugural Health Care Conference will bring together firm experts, in-house counsel, regulators and policy leaders, and healthcare specialists for a full-day of education and networking. Topics will cover a variety of legal trends and developments affecting health care providers and institutions, payers, insurers, physicians and medical groups, pharmaceutical and medical device companies, and more.


8:00 AM – 9:00 AM

Check-in and Breakfast

9:00 AM – 10:30 AM

Data Sharing Across the Health Care Industry

  • Moderator: Lois Johnson, General Counsel, Massachusetts Health Policy Commission
  • Joshua Abrams, Senior Legal Counsel, Partners HealthCare System
  • Emily Kretchmer, Partner, Krokidas and Bluestein LLP
  • Judith Phillips Dolgin, Corporate Counsel, Patient Ping
  • Erika Snyder, Vice President and Assistant General Counsel, Fresenius Medical Care North America
  • Lisa Thompson, Partner, Robinson & Cole LLP

10:45 AM – 12:15 PM

Innovations in Health Care

  • Moderator: Brad Gay, Senior Vice President and General Counsel, American Well
  • Moderator: Michael Gibbs, Vice President and General Counsel, T2 Biosystems
  • Dr. Peter Antall, Chief Medical Officer, American Well
  • Steve Bernstein, Partner, McDermott, Will & Emery
  • Melissa Bradley, Associate General Counsel, Blue Cross Blue Shield of Massachusetts
  • Alexis Gilroy, Partner, Jones Day
  • Colin Zick, Partner, Foley Hoag

12:15 PM – 1:30 PM




1:45 PM – 2:45 PM

Drug Pricing

  • Moderator: Michael Cannella, Legislative Director & Counsel, Massachusetts State Senate
  • Representative Christine P. Barber, Massachusetts House of Representatives
  • Senator Jason M. Lewis, Massachusetts State Senate

Healthcare Marketplace Trends

This panel will provide an overview of the legal and operational issues associated with payor/provider joint ventures from the perspective of two seasoned healthcare attorneys who navigated this terrain together and came out on the other side. Moderated by the always engaging Jim Roosevelt, this panel is a must for any practitioners working with or advising payors or providers on ACO, shared savings and other joint contracting arrangements.

  • Moderator: James Roosevelt, Jr., Counsel, Verrill Dana LLP
  • Serina Barkley, Associate General Counsel, Tufts Health Plan
  • Andrea Synnott, Associate General Counsel, Cambridge Health Alliance
  • Megan Wulff, Deputy Director, Massachusetts Health Policy Commission

3:00 PM – 4:00 PM

Health Care Enforcement: What’s on the Horizon?

Hear about criminal and civil enforcement trends from the perspective of the head of Massachusetts federal and state health care fraud prosecution units, a defense attorney and in-house counsel.

  • Moderator: Michele Adelman, Deputy General Counsel, Regulatory, Fresenius Medical Care, North America
  • Maria Durant, Partner, Hogan Lovells LLP
  • Angela Neal, Director, Associate General Counsel, DentaQuest
  • Amanda Strachan, Acting Chief, Health Care Fraud Unit, U.S. Attorney’s Office
  • Toby Unger, Chief, Medicaid Fraud Division, Massachusetts Attorney General’s Office

Right to Try and Expanded Access to Investigational Drugs

The federal “Right to Try” law enacted in 2018 has brought new attention to the issue of patient access to investigational drugs, although regulatory pathways for obtaining such access through the Food and Drug Administration (FDA) have existed since 1987.  This session will provide a brief history, overview, and comparison of the key features of the Right to Try law and of the current FDA Expanded Access program.  Panelists from legal and FDA regulatory backgrounds, a pharmaceutical company, and an academic health system will then provide perspectives on the impact of the Right to Try law on patient care, industry, providers and other stakeholders.  Panelists will also discuss key considerations for developing or revising policies to address access requests. 

  • Moderator: Emily Chi Fogler, Partner, Verrill Dana, LLP
  • Marylana Saadeh Helou, Associate, Verrill Dana, LLP
  • Richard Klein, Consultant and Former Director of the FDA Patient Liaison Program
  • Christine MacCracken, MSHEd, BSN, Director, Patient Support, Janssen Pharmaceuticals, Office of the Chief Medical Officer
  • Pearl O’Rourke, MD, Director, Human Research Affairs, Partners HealthCare System

4:00 PM – 5:00 PM

Behavioral Health

Panelists will address challenging legal issues pertaining to commitments under Chapter 123 of the Massachusetts General Laws, problems with mental health parity and recently proposed legislation in Massachusetts to address these issues, and the Office of the Attorney General’s enforcement work with a focus on the Purdue/Sackler opioid litigation.

  • Moderator: Rochelle Zapol, Member, Institutional Review Board, Dana-Farber Cancer Institute
  • Sandy Alexander, Assistant Attorney General, Office of the Massachusetts Attorney General
  • Diane Baiano, St. Elizabeth’s Medical Center
  • David Matteodo, Executive Director, Massachusetts Association of Behavioral Health Systems

Hot Topics in Reimbursement: Provider-based and Overpayments/Recoupments

While there are many hot topics in reimbursement, we polled the audience and found that members were most interested in provider-based issues as well as third party payor overpayments and recoupments. Come hear from our experts who will discuss the current state of provider-based including the most recent site neutral payment policy released in the 2019 HOPPS final rule as well as practical tips and tricks for navigating overpayments and recoupments with Medicare, MassHealth and commercial payors.  

  • Moderator: Meghan Cosgrove, Partner, Barrett & Singal
  • Moderator: Gary Rosenberg, Partner, Verrill Dana
  • Greg Russo, Managing Director, Berkeley Research Group
  • Adrianne Ortega, Partner, Ropes & Gray
  • Michael Somers, Assistant General Counsel, Massachusetts Executive Office of Health and Human Services
  • Joshua Orr, Director, Fraud Prevention and Recovery, Tufts Health Plan
  • Adria Warren, Partner, Foley & Lardner

5:00 PM

Networking Reception

Advisory Committee

Michele Adelman
Deputy General Counsel, Regulatory
Fresenius Medical Care, North America

Maureen Bennett
Jones Day

Emily Chi Fogler
Verrill Dana LLP

Meghan Cosgrove
Barrett & Singal

Brad Gay
Senior Vice President & General Counsel
American Well

Joe Nevins
VP & Deputy General Counsel
Blue Cross Blue Shield of Massachusetts

Bert Ng
Mass HIway Program Director
Massachusetts Executive Office of
Health and Human Services

Lisa Thompson
Partner, Robinson & Cole LLP

Rochelle Zapol
Member of an Institutional Review Board
Dana-Farber Cancer Institute


Boston Bar Members – $325.00
Government Members – $250.00

Non-Member Guests – $425.00

To reserve your seat, create a New User account -or- contact Rachel Andreas: 617.778.1904

Thank You to Our Sponsors

Scroll to top